Statin Pharmacogenomics: Opportunities to Improve Patient Outcomes and Healthcare Costs with Genetic Testing

HMG-CoA reductase inhibitors, commonly known as statins, are some of the most widely prescribed medications worldwide and have been shown to be effective at lowering cholesterol in numerous long-term prospective trials, yet there are significant limitations to their use. First, patients receiving st...

Descripción completa

Detalles Bibliográficos
Autores principales: Canestaro, William J., Brooks, David G., Chaplin, Donald, Choudhry, Niteesh K., Lawler, Elizabeth, Martell, Lori, Brennan, Troyen, Wassman, E. Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2012
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251374/
https://www.ncbi.nlm.nih.gov/pubmed/25562358
http://dx.doi.org/10.3390/jpm2040158

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251374/
https://www.ncbi.nlm.nih.gov/pubmed/25562358
http://dx.doi.org/10.3390/jpm2040158

Ejemplares similares